CELLECTAR BIOSCIENCES, INC.

Profile

Company Names

CELLECTAR BIOSCIENCES, INC.
NOVELOS THERAPEUTICS, INC.

Addresses

100 CAMPUS DRIVE, SUITE 207, FLORHAM PARK, NJ 07932

100 CAMPUS DRIVE, FLORHAM PARK, NJ 07932

3301 AGRICULTURE DRIVE, MADISON, WI 53716

ONE GATEWAY CENTER, SUITE 504, NEWTON, MA 02458

Phone Numbers

(608) 441-8120
608-441-8120
617-244-1616

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DE

Total Amount Raised:

$108,313,560.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2023-09-08 
$24,500,000.00 
$24,500,000.00 
$0.00 
Equity 
8
2020-12-28 
$20,499,993.00 
$20,499,993.00 
$0.00 
Equity 
7
2019-05-20 
$5,045,000.00 
$14,645,000.00 
$9,600,000.00 
Equity 
6
2017-10-12 
$7,766,164.00 
$7,766,164.00 
$0.00 
Equity 
5
2014-08-01 
$617,500.00 
$1,000,000.00 
$382,500.00 
Debt 
4
2011-04-08 
$5,134,903.00 
$5,134,903.00 
$0.00 
Equity 
3
2009-08-26 
$3,500,000.00 
$9,000,000.00 
$5,500,000.00 
Equity 
2
2009-08-25 
$9,000,000.00 
$9,000,000.00 
$0.00 
Equity 
1
2009-02-11 
$32,250,000.00 
$32,250,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHARLES 
T. 
BERNHARDT 
EXECUTIVE OFFICER
CELLECTAR BIOSCIENCES, INC.
PAUL 
 
BERNS 
DIRECTOR
ANACOR PHARMACEUTICALS, INC.   |  CELLECTAR BIOSCIENCES, INC.   |  UNITY BIOTECHNOLOGY, INC.   |  ARCH VENTURE FUND XII, L.P.   |  ELEPHAS BIOSCIENCES CORP   |  ARETEIA THERAPEUTICS, INC.   |  NEUMORA THERAPEUTICS, INC.   |  MIRADOR THERAPEUTICS, INC.   |  OLLIN BIOSCIENCES, INC.
JAMES 
V. 
CARUSO 
EXECUTIVE OFFICER, DIRECTOR
CELLECTAR BIOSCIENCES, INC.
ASHER 
ALBAN 
CHANAN-KAHN 
DIRECTOR
CELLECTAR BIOSCIENCES, INC.
MICHAEL 
J. 
DOYLE 
DIRECTOR
NOVELOS THERAPEUTICS, INC.   |  MEDSPHERE SYSTEMS CORP   |  QPID, INC.
FREDERICK 
W 
DRISCOLL 
DIRECTOR
CELLECTAR BIOSCIENCES, INC.
FREDERICK 
W. 
DRISCOLL 
DIRECTOR
CELLECTAR BIOSCIENCES, INC.   |  MEI PHARMA, INC.
DOV 
 
ELEFANT 
EXECUTIVE OFFICER
MORRIA BIOPHARMACEUTICALS PLC   |  CELSUS THERAPEUTICS PLC.   |  AKARI THERAPEUTICS PLC   |  CELLECTAR BIOSCIENCES, INC.   |  FEMASYS INC
SIMM 
 
FASS 
DIRECTOR
NOVELOS THERAPEUTICS, INC.
JOHN 
 
FRIEND 
DIRECTOR
TMC CARDIAC + CARDIOTHORACIC SURGERY MANAGEMENT, LLC   |  BAKERCORP INTERNATIONAL HOLDINGS, INC.   |  NEXVISION REAL ESTATE, INC.   |  GUARDIAN ALLIANCE TECHNOLOGIES, INC.   |  CELLECTAR BIOSCIENCES, INC.   |  KAZIA THERAPEUTICS LTD
JOHN 
E. 
FRIEND II 
EXECUTIVE OFFICER
CELLECTAR BIOSCIENCES, INC.
JOHN 
P. 
HAMILL 
EXECUTIVE OFFICER
CELLECTAR BIOSCIENCES, INC.   |  APREA THERAPEUTICS, INC.
KIM 
 
HAWKINS 
EXECUTIVE OFFICER
NOVELOS THERAPEUTICS, INC.
STEPHEN 
A. 
HILL 
DIRECTOR
NOVELOS THERAPEUTICS, INC.   |  CELLECTAR BIOSCIENCES, INC.
CHAD 
J. 
KOLEAN 
EXECUTIVE OFFICER
CELLECTAR BIOSCIENCES, INC.
DARRELL 
SHANE 
LEA 
EXECUTIVE OFFICER
CELLECTAR BIOSCIENCES, INC.
JARROD 
 
LONGCOR 
EXECUTIVE OFFICER
CELLECTAR BIOSCIENCES, INC.
STEFAN 
 
LOREN 
DIRECTOR
MARINA BIOTECH, INC.   |  CELLECTAR BIOSCIENCES, INC.
STEFAN 
D. 
LOREN 
DIRECTOR
CELLECTAR BIOSCIENCES, INC.
THOMAS 
ROCKWELL 
MACKIE 
DIRECTOR
SHINE MEDICAL TECHNOLOGIES, INC.   |  NOVELOS THERAPEUTICS, INC.   |  HEALTHMYNE, INC.   |  ILLUMINATED HOLDINGS, INC.
JAMES 
S. 
MANUSO 
DIRECTOR
NOVELOS THERAPEUTICS, INC.   |  RESPIRERX PHARMACEUTICALS INC.   |  OCUPHIRE PHARMA, INC.
DAVID 
B. 
MCWILLIAMS 
DIRECTOR
NOVELOS THERAPEUTICS, INC.   |  OPEXA THERAPEUTICS, INC.
JOHN 
E. 
NEIDERHUBER 
DIRECTOR
NOVELOS THERAPEUTICS, INC.
JOHN 
 
NEIS 
DIRECTOR
INVIRAGEN, INC.   |  VIRENT ENERGY SYSTEMS INC   |  NOVELOS THERAPEUTICS, INC.   |  CELLECTAR BIOSCIENCES, INC.   |  GREAT LAKES PHARMACEUTICALS, INC.   |  DELPHINUS MEDICAL TECHNOLOGIES, INC.   |  TAI DIAGNOSTICS, INC.   |  VENTURE INVESTORS HEALTH FUND 6 LIMITED PARTNERSHIP   |  HEALTH SCHOLARS, INC.   |  VENTURE INVESTORS HEALTH FUND 7 LIMITED PARTNERSHIP
ELIAS 
 
NYBERG 
EXECUTIVE OFFICER
NOVELOS THERAPEUTICS, INC.
HARRY 
S. 
PALMIN 
DIRECTOR, EXECUTIVE OFFICER
NOVELOS THERAPEUTICS, INC.   |  ACER THERAPEUTICS INC.   |  ACER THERAPEUTICS INC.
CHRISTOPHER 
J. 
PAZOLES 
EXECUTIVE OFFICER
NOVELOS THERAPEUTICS, INC.
SIMON 
 
PEDDER 
EXECUTIVE OFFICER, DIRECTOR
CELLECTAR BIOSCIENCES, INC.   |  BALLANTYNE THERAPEUTICS, INC.   |  ATHENEX, INC.   |  ADAPTIN BIO, INC.
JOANNE 
M. 
PROTANO 
EXECUTIVE OFFICER
NOVELOS THERAPEUTICS, INC.
HOWARD 
M. 
SCHNEIDER 
DIRECTOR
NOVELOS THERAPEUTICS, INC.
KRISTIN 
C. 
SCHUHWERK 
EXECUTIVE OFFICER
NOVELOS THERAPEUTICS, INC.
ANDREI 
 
SHUSTOV 
EXECUTIVE OFFICER
CELLECTAR BIOSCIENCES, INC.
DOUGLAS 
J. 
SWIRSKY 
DIRECTOR
GENVEC INC   |  FIBROCELL SCIENCE, INC.   |  CELLECTAR BIOSCIENCES, INC.   |  AAVANTIBIO, INC.   |  NEUROBO PHARMACEUTICALS, INC.
MICHAEL 
F. 
TWEEDLE 
DIRECTOR
NOVELOS THERAPEUTICS, INC.
JAMEY 
P. 
WEICHERT 
EXECUTIVE OFFICER, DIRECTOR
NOVELOS THERAPEUTICS, INC.   |  CELLECTAR BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-09-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-09-08 
2021-01-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2020-12-28 
2019-05-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2019-05-20 
2017-10-13
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2017-10-12 
2014-08-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2014-08-01 
2011-04-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2011-04-08 
2009-11-19
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2009-08-25 
2009-09-09
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2009-08-26 
2009-02-26
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2009-02-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
OPPENHEIMER + CO. INC.
249
NONE
NONE
OPPENHEIMER + CO. INC
NONE
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
15407
NONE
NONE
LANDENBURG THALMANN + CO. INC.
505
FERGHANA SECURITIES, INC.
43430
FERGHANA PARTNERS, LP
NONE